<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:49:13 -0700</creation_date>
  <update_date>2013-05-27 11:22:36 -0600</update_date>
  <accession>HMDBP00166</accession>
  <secondary_accessions>
    <accession>5398</accession>
  </secondary_accessions>
  <protein_type>Unknown</protein_type>
  <synonyms>
    <synonym>IVD</synonym>
  </synonyms>
  <gene_name>IVD</gene_name>
  <general_function>Involved in acyl-CoA dehydrogenase activity</general_function>
  <specific_function></specific_function>
  <pathways>
    <pathway>
      <name>L-leucine degradation</name>
      <smpdb_id/>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Valine, leucine and isoleucine degradation</name>
      <smpdb_id/>
      <kegg_map_id>map00280</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB01113</accession>
      <name>Isovaleryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01493</accession>
      <name>3-Methylcrotonyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01248</accession>
      <name>FAD</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04949</accession>
      <name>Ceramide (d18:1/16:0)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01197</accession>
      <name>FADH</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01338</accession>
      <name>Palmityl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06497</accession>
      <name>Heptadecanoyl CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01114</accession>
      <name>Stearoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04258</accession>
      <name>Eicosanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01206</accession>
      <name>Acetyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01275</accession>
      <name>Propionyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01088</accession>
      <name>Butyryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13037</accession>
      <name>Pentanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12969</accession>
      <name>Heptanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01070</accession>
      <name>Octanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13028</accession>
      <name>Nonanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06404</accession>
      <name>Decanoyl-CoA (n-C10:0CoA)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13114</accession>
      <name>Undecanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03571</accession>
      <name>Lauroyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06526</accession>
      <name>Tetracosanoyl-CoA  </name>
    </metabolite>
    <metabolite>
      <accession>HMDB02009</accession>
      <name>Crotonoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01290</accession>
      <name>Glutaconyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03944</accession>
      <name>trans-2-Hexenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03949</accession>
      <name>(2E)-Octenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03948</accession>
      <name>(2E)-Decenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03946</accession>
      <name>(2E)-Tetradecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04257</accession>
      <name>3Z-dodecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03712</accession>
      <name>(2E)-Dodecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01243</accession>
      <name>Isobutyryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11660</accession>
      <name>2-Methylhexanoyl-CoA </name>
    </metabolite>
    <metabolite>
      <accession>HMDB02057</accession>
      <name>Pristanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01041</accession>
      <name>2-Methylbutyryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02307</accession>
      <name>Acrylyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03945</accession>
      <name>(2E)-Hexadecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06529</accession>
      <name>trans-Octadec-2-enoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02845</accession>
      <name>Hexanoyl-CoA</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>nucleoside binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>purine nucleoside binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>adenyl nucleotide binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>fad or fadh2 binding</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>oxidoreductase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>oxidoreductase activity, acting on the ch-ch group of donors</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>acyl-coa dehydrogenase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>oxidation reduction</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>mitochondrial matrix</description>
      <go_id>GO:0005759</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>mitochondrial membrane</description>
      <go_id>GO:0031966</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>acyl-CoA dehydrogenase activity</description>
      <go_id>GO:0003995</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>flavin adenine dinucleotide binding</description>
      <go_id>GO:0050660</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>isovaleryl-CoA dehydrogenase activity</description>
      <go_id>GO:0008470</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cellular nitrogen compound metabolic process</description>
      <go_id>GO:0034641</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>leucine catabolic process</description>
      <go_id>GO:0006552</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Mitochondrion matrix</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>15</chromosome_location>
    <locus>15q14-q15</locus>
    <gene_sequence>&gt;1272 bp
ATGGCGACTGCGACTCGGCTGCTGGGGTGGCGTGTGGCGAGCTGGAGGCTGCGGCCGCCG
CTTGCCGGCTTCGTTTCCCAGCGGGCCCACTCGCTTTTGCCCGTGGACGATGCAATCAAT
GGGCTAAGCGAGGAGCAGAGGCAGCTTCGTCAGACCATGGCTAAGTTCCTTCAGGAGCAC
CTGGCCCCCAAGGCCCAGGAGATCGATCGCAGCAATGAGTTCAAGAACCTGCGAGAATTT
TGGAAGCAGCTGGGGAACCTGGGCGTATTGGGCATCACAGCCCCTGTTCAGTATGGCGGC
TCCGGCCTGGGCTACCTGGAGCATGTGCTGGTGATGGAGGAGATATCCCGAGCTTCCGGA
GCAGTGGGGCTCAGTTACGGTGCCCACTCCAACCTCTGCATCAACCAGCTTGTACGCAAT
GGGAATGAGGCCCAGAAAGAGAAGTATCTCCCGAAGCTGATCAGTGGTGAGTACATCGGA
GCCCTGGCCATGAGTGAGCCCAATGCAGGCTCTGATGTTGTCTCTATGAAGCTCAAAGCG
GAAAAGAAAGGAAATCACTACATCCTGAATGGCAACAAGTTCTGGATCACTAATGGCCCT
GATGCTGACGTCCTGATTGTCTATGCCAAGACAGATCTGGCTGCTGTGCCAGCTTCTCGG
GGCATCACAGCCTTCATTGTGGAGAAGGGTATGCCTGGCTTTAGCACCTCTAAGAAGCTG
GACAAGCTGGGGATGAGGGGCTCTAACACCTGTGAGCTAATCTTTGAAGACTGCAAGATT
CCTGCTGCCAACATCCTGGGCCATGAGAATAAGGGTGTCTACGTGCTGATGAGTGGGCTG
GACCTGGAGCGGCTGGTGCTGGCCGGGGGGCCTCTTGGGCTCATGCAAGCGGTCCTGGAC
CACACCATTCCCTACCTGCACGTGAGGGAAGCCTTTGGCCAGAAGATCGGCCACTTCCAG
TTGATGCAGGGGAAGATGGCTGACATGTACACCCGCCTCATGGCGTGTCGGCAGTATGTC
TACAATGTCGCCAAGGCCTGCGATGAGGGCCATTGCACTGCTAAGGACTGTGCAGGTGTG
ATTCTTTACTCAGCTGAGTGTGCTACACAGGTAGCCCTGGACGGCATTCAGTGTTTTGGT
GGCAATGGCTACATCAATGACTTTCCCATGGGCCGCTTTCTTCGAGATGCCAAGCTGTAT
GAGATAGGGGCTGGGACCAGCGAGGTGAGGCGGCTGGTCATCGGCAGAGCCTTCAATGCA
GACTTTCACTAG</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>423</residue_number>
    <molecular_weight>43055.325</molecular_weight>
    <theoretical_pi>7.672</theoretical_pi>
    <pfams>
      <pfam>
        <name>Acyl-CoA_dh_1</name>
        <pfam_id>PF00441</pfam_id>
      </pfam>
      <pfam>
        <name>Acyl-CoA_dh_M</name>
        <pfam_id>PF02770</pfam_id>
      </pfam>
      <pfam>
        <name>Acyl-CoA_dh_N</name>
        <pfam_id>PF02771</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Isovaleryl-CoA dehydrogenase, mitochondrial
MATATRLLGWRVASWRLRPPLAGFVSQRAHSLLPVDDAINGLSEEQRQLRQTMAKFLQEH
LAPKAQEIDRSNEFKNLREFWKQLGNLGVLGITAPVQYGGSGLGYLEHVLVMEEISRASG
AVGLSYGAHSNLCINQLVRNGNEAQKEKYLPKLISGEYIGALAMSEPNAGSDVVSMKLKA
EKKGNHYILNGNKFWITNGPDADVLIVYAKTDLAAVPASRGITAFIVEKGMPGFSTSKKL
DKLGMRGSNTCELIFEDCKIPAANILGHENKGVYVLMSGLDLERLVLAGGPLGLMQAVLD
HTIPYLHVREAFGQKIGHFQLMQGKMADMYTRLMACRQYVYNVAKACDEGHCTAKDCAGV
ILYSAECATQVALDGIQCFGGNGYINDFPMGRFLRDAKLYEIGAGTSEVRRLVIGRAFNA
DFH</protein_sequence>
  </protein_properties>
  <genbank_protein_id>306897</genbank_protein_id>
  <uniprot_id>P26440</uniprot_id>
  <uniprot_name>IVD_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1IVH</pdb_id>
  </pdb_ids>
  <genbank_gene_id>M34192</genbank_gene_id>
  <genecard_id>IVD</genecard_id>
  <geneatlas_id>IVD</geneatlas_id>
  <hgnc_id>HGNC:6186</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Matsubara Y, Ito M, Glassberg R, Satyabhama S, Ikeda Y, Tanaka K: Nucleotide sequence of messenger RNA encoding human isovaleryl-coenzyme A dehydrogenase and its expression in isovaleric acidemia fibroblasts. J Clin Invest. 1990 Apr;85(4):1058-64.</reference_text>
      <pubmed_id>2318964</pubmed_id>
    </reference>
    <reference>
      <reference_text>Vockley J, Rogan PK, Anderson BD, Willard J, Seelan RS, Smith DI, Liu W: Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. Am J Hum Genet. 2000 Feb;66(2):356-67.</reference_text>
      <pubmed_id>10677295</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Parimoo B, Tanaka K: Structural organization of the human isovaleryl-CoA dehydrogenase gene.  Genomics. 1993 Mar;15(3):582-90.</reference_text>
      <pubmed_id>8468053</pubmed_id>
    </reference>
    <reference>
      <reference_text>Vockley J, Nagao M, Parimoo B, Tanaka K: The variant human isovaleryl-CoA dehydrogenase gene responsible for type II isovaleric acidemia determines an RNA splicing error, leading to the deletion of the entire second coding exon and the production of a truncated precursor protein that interacts poorly with mitochondrial import receptors. J Biol Chem. 1992 Feb 5;267(4):2494-501.</reference_text>
      <pubmed_id>1310317</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.</reference_text>
      <pubmed_id>12665801</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mohsen AW, Vockley J: Identification of the active site catalytic residue in human isovaleryl-CoA dehydrogenase. Biochemistry. 1995 Aug 15;34(32):10146-52.</reference_text>
      <pubmed_id>7640268</pubmed_id>
    </reference>
    <reference>
      <reference_text>Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M: Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40. Epub 2009 Jul 16.</reference_text>
      <pubmed_id>19608861</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tiffany KA, Roberts DL, Wang M, Paschke R, Mohsen AW, Vockley J, Kim JJ: Structure of human isovaleryl-CoA dehydrogenase at 2.6 A resolution: structural basis for substrate specificity,. Biochemistry. 1997 Jul 15;36(28):8455-64.</reference_text>
      <pubmed_id>9214289</pubmed_id>
    </reference>
    <reference>
      <reference_text>Vockley J, Parimoo B, Tanaka K: Molecular characterization of four different classes of mutations in the isovaleryl-CoA dehydrogenase gene responsible for isovaleric acidemia. Am J Hum Genet. 1991 Jul;49(1):147-57.</reference_text>
      <pubmed_id>2063866</pubmed_id>
    </reference>
    <reference>
      <reference_text>Mohsen AW, Anderson BD, Volchenboum SL, Battaile KP, Tiffany K, Roberts D, Kim JJ, Vockley J: Characterization of molecular defects in isovaleryl-CoA dehydrogenase in patients with isovaleric acidemia. Biochemistry. 1998 Jul 14;37(28):10325-35.</reference_text>
      <pubmed_id>9665741</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
  </metabolite_references>
</protein>
